Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Kestra Medical Technologies (NASDAQ: KMTS) will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 2:15 p.m. PT.
Investors and interested parties can access a live webcast and replay via the company's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – KMTS
In the Dec 30 session, KMTS gained 2.02%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 11 | Earnings results | Positive | +1.6% | Reported strong Q2 FY2026 growth and raised full-year revenue guidance. |
| Dec 03 | Earnings date notice | Neutral | +12.2% | Announced timing and access details for upcoming Q2 FY2026 results call. |
| Dec 02 | Equity offering priced | Negative | -6.8% | Priced upsized public offering of 6,000,000 common shares at $23.00. |
| Dec 01 | Equity offering launch | Negative | -8.5% | Proposed underwritten public offering of 5,500,000 shares with overallotment. |
| Dec 01 | Preliminary earnings | Positive | -8.5% | Preliminary Q2 results showed ~52% revenue growth and ~50% gross margin. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news reactions show mostly aligned moves: positive earnings and financing announcements generally saw price changes consistent with their tone, except for a divergence on preliminary earnings where strong growth coincided with a negative move.
Over the last month, KMTS has reported strong growth, with Q2 FY2026 revenue of $22.6M, up 53% year over year, and gross margin improving to 50.6%. The company completed an upsized public offering of 6,000,000 shares at $23.00, following a proposed 5,500,000-share offering on Dec 1, 2025. Preliminary Q2 results and the final earnings release both highlighted robust momentum, and today’s conference appearance fits into an active investor communication pattern.
Key Terms
wearable medical device medical
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
KIRKLAND, Wash., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 2:15 p.m. Pacific Time.
Interested parties may access the live webcast and replay of the presentation by visiting the Kestra Medical Technologies investor relations website.
About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact Neil Bhalodkar neil.bhalodkar@kestramedical.com